Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis. [electronic resource]
Producer: 20090903Description: 1316-21 p. digitalISSN:- 1468-2060
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- therapeutic use
- Apolipoprotein A-I -- blood
- Arthritis, Rheumatoid -- blood
- Biomarkers -- metabolism
- C-Reactive Protein -- metabolism
- Cholesterol, HDL -- blood
- Down-Regulation -- drug effects
- Female
- Humans
- Inflammation Mediators -- blood
- Lipids -- blood
- Macrophage Migration-Inhibitory Factors -- blood
- Male
- Middle Aged
- Severity of Illness Index
- Sex Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.